About admin

This author has not yet filled in any details.
So far admin has created 20 blog entries.

Virpax Pharmaceuticals Announces Successful Completion of Pre-IND Meeting with FDA on NES100 for the Management of Acute and Chronic Pain

2020-03-01T14:50:40-05:00March 2nd, 2020|Press Release|

Virpax Pharmaceuticals Inc. (“Virpax”), a company specializing in developing pharmaceutical products for pain management by using new drug delivery systems today announced that it has successfully completed a pre-Investigational New Drug (IND) Application meeting with the U.S. Food [...]

Virpax Pharmaceuticals Selected for Two Presentations at the 2020 Special Operations Medical Association Exhibition

2020-02-24T01:26:45-05:00February 5th, 2020|Press Release|

Virpax Pharmaceuticals, Inc. (“Virpax”), a company specializing in developing pharmaceutical products for pain management, today announced that their Chief Medical Officer Jeffrey Gudin, M.D., will present two abstracts at the 2020 Special Operations Medical Association’s Training, Education, Scientific Assembly [...]

Virpax Pharmaceuticals Announces the Proposed Development of A Long Acting Naloxone and Naltrexone Liposomal Delivery To Reverse Opioid Related Respiratory Depression

2020-02-23T02:26:52-05:00August 13th, 2019|Press Release|

Virpax Pharmaceuticals, Inc. (“Virpax”), a company specializing in developing pharmaceutical products for pain management, announced today that it proposes the development of a naloxone/naltrexone IP-protected formulation (RES202) consisting of liposomes embedded in a hydrogel or a lyophilized formulation [...]